Table 7.

Responses to the open-ended question about factors that might influence deprescription

Categories		Examples	GP, n (%)
Conscience		• “Making life easier for the patient who has less medication to take” • “Sensitivity of the impact of each drug on quality of life”	2 (1.45)
Inertia	Attitudes and Beliefs	• “Adverse effects” • “Benefit-risk of the drug” • “Medication intolerance” • “Psychological effect of deprescription on the patient” • “Pharmacodynamics and pharmacokinetics” • “Fears and beliefs of the physician; defensive medicine”	17 (12.32)
	Behaviour	• “Who prescribed it (GFM versus hospital)” • “Withdrawing medication prescribed by other doctors a long time ago (especially privately)”	2 (1.45)
Self-efficacy	Information/ Influence	• “Non-medical advertising about the medication” • “Association of the drug with the physician who prescribed it, who was very good” • “Lack of communication between specialties” • Non-existence of guidelines • “Opinion of other physicians who follow the patient”	8 (5.8)
	Capabilities/ Knowledge	• “Physician’s prior knowledge” • “Prior experience with deprescription” • “Unawareness” • “Professional training”	11 (7.97)
Feasibility	Regulation	• “Factors related to clinical governance and safety culture”	1 (0.72)
	Health culture		0
	Medical Culture		0
	Clinical practice		0
	Resources (psychosocial support)	• “Family/social support • “Existence of alternatives” • “Feedback from pharmacies” • “Other priority actions” • “Consultation time”	20 (14.49)
	Patient (will, preference, etc.)	• “The patient’s adhesion” • The patient’s willingness • Acceptance of the patient/relatives • “Background, degree of dependence, frailty” • Patient’s beliefs • Literacy • Economic aspects”	73 (52.9)
Non codable		• “Difficulty in effectively controlling complaints” • “Control test results; controlled diet” • “Changes in habits of the user that no longer justify taking the medication” • “Anxiety disorders/psychiatric illness in general”	4 (2.9)
Total			138